Understanding how Ewing Sarcoma cells avoid natural defenses
Mechanisms underlying USP1-mediated bypass of EWS-FLI1 oncogene-induced replication stress in Ewing sarcoma
This research explores how Ewing sarcoma cancer cells manage to keep growing even when they should stop or die, focusing on a protein called USP1.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nebraska Medical Center NIH-funded |
| Lab location | 1 site (Omaha, United States) |
| Project ID | NIH-11139515 on NIH RePORTER |
What this research studies
Normally, our bodies have ways to stop cancer cells from growing out of control, like making them age or die when they have too much stress. However, Ewing sarcoma cells find a way around these natural defenses, allowing them to multiply unchecked. This project aims to uncover the specific ways these cancer cells bypass these protective systems. We are particularly interested in a protein called USP1, which appears to be overactive in Ewing sarcoma and might be helping these cells survive. By understanding this process, we hope to find new ways to target and treat this aggressive bone cancer.
Who could benefit from this research
Good fit: This foundational research is for future patients with Ewing sarcoma, as it aims to uncover new treatment strategies for this specific type of bone cancer.
Not a fit: Patients with other types of cancer or conditions not related to Ewing sarcoma may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this research could identify new targets for medications that could stop Ewing sarcoma cells from growing, potentially leading to more effective treatments.
How similar studies have performed: While the specific mechanism being studied is largely unknown, preliminary data from this team suggests that the USP1 protein is involved in Ewing sarcoma.
Where this research is happening
Omaha, United States
- University of Nebraska Medical Center — Omaha, United States (Active)
Researchers
- Principal investigator: Ghosal, Gargi — University of Nebraska Medical Center
- Study coordinator: Ghosal, Gargi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.